Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs Intravenous Antibiotics for Diabetic Foot Osteomyelitis
NCT02168816Phase 2Terminated
- Sponsor
- Loyola University Chicago
- Start
- Mar 2014
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in diabetic foot osteomyelitis (DFO) (3 arms), sponsored by Loyola University Chicago. Primary endpoint: Number of Participants With Bone Infection at 6 months. Started Mar 2014; status: terminated.
02
Conditions
diabetic foot osteomyelitis (DFO)
Beyond the preview
Go deeper on NCT02168816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02168816.